Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.
Paez
Jorge G
JG
Levin
Anna S
AS
Basso
Mariusa
M
Gomez
Laura B
LB
Gobara
Satiko
S
Spadão
Fernanda
F
Oshiro
Isabel
I
Costa
Silvia Figueiredo
SF
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000453:epidemiology* / Q000382:microbiology; D001938:Brazil / Q000453:epidemiology; D015780:Carbapenems / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D016905:Gram-Negative Bacterial Infections / Q000453:epidemiology* / Q000382:microbiology; D006785:Hospitals, University; D006801:Humans; D015994:Incidence; D020615:Stenotrophomonas maltophilia; D047090:beta-Lactams / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D002511:Cephalosporins; D047090:beta-Lactams